Furthermore, in diseases such as obesity and metabolic syndrome, ANP levels are lower than in healthy individuals, probably due to both increased clearance and reduced synthesis; based on the above, an inverse–proportionality relationship between ANP levels and cardiac mass has been reported in these subjects, with pronounced myocardial hypertrophy [126]. The gene discussed is NPPA; the disease is obesity disorder.